Björklund Pharma AS, based in Mo i Rana, Northern Norway, is a small, early-stage biopharmaceutical company fully owned by Bolna AS. Led by Geir Bjørklund, MD, it advances healthcare through evidence-based product development using biofactors and natural compounds, and makes carefully chosen investments in promising biotech, medtech, and niche life science ventures. Through scientific and strategic innovation, Björklund Pharma aims to address complex medical challenges and improve patient outcomes.